Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Mezagitamab
Trade Name
Synonyms TAK079|TAK 079|TAK-079
Drug Descriptions

Mezagitamab (TAK-079) is a monoclonal antibody that targets CD38, which has potential cytolytic effects against CD38-expressing cells (J Immunol May 1, 2017, 198 (1 Supplement) 224.20, PMID: 32045493).

DrugClasses CD38 Antibody 20
CAS Registry Number 2227490-52-8
NCIT ID C148078


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bortezomib + Dexamethasone + Lenalidomide + Mezagitamab Bortezomib Dexamethasone Lenalidomide Mezagitamab 0 1
Dexamethasone + Lenalidomide + Mezagitamab Dexamethasone Lenalidomide Mezagitamab 0 1
Dexamethasone + Mezagitamab + Pomalidomide Dexamethasone Mezagitamab Pomalidomide 0 1
Mezagitamab Mezagitamab 0 1
Mezagitamab + Subasumstat Mezagitamab Subasumstat 0 1

Additional content available in CKB BOOST